RBR-3r88x9进行中（未招募）4 期
se of Goserelin for medical treatment of Uterine fibroids
Financiamento próprio0 个研究点开始时间: 2018年7月24日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Intervention
入排标准
- 年龄范围
- 18Y 至 55Y（—）
- 性别
- Female
入选标准
- •Woman; older than 18 year; diagnosis of uterine fibroids
排除标准
- •Menopause; cancer; drug hypersensitivity
研究者
相似试验
撤回
3 期
Protection of Ovarian Function With Goserelin Acetate in Premenopausal Early Breast Cancer Patients With ChemotherapyOvarian FunctionBreast CancerNCT00888082AstraZeneca102
已完成
3 期
S0230 Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast CancerMenopausal SymptomsBreast CancerInfertilityNCT00068601SWOG Cancer Research Network257
已完成
1 期
COMPARISON OF A NEW FORMULATION OF GOSERELIN (Pepti 3.6 mg) to Zoladex® 3.6 mgDysfunctional Uterine BleedingNCT04428684Peptigroupe Inc.80
已完成
不适用
Prospective study of neoadjuvant goserelin, anastrozole and radiotherapy for hormone-responsive premenopausal breast cancerearly breast cancerJPRN-UMIN000006049Osaka Medical Center for Cancer and Cardiovascular Diseases35
进行中（未招募）
不适用
Study of Preservation of Ovarian Reserve During Chemotherapy for Young Breast Cancer PatientsBreast CancerNCT02430103Peking University People's Hospital349